Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Completed 46Unknown 15Not yet recruiting 5Terminated 4Withdrawn 3Recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1Breast 1

Conditions

Pain, Postoperative 3Urinary Bladder Neoplasms 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Ropivacaine × Clear all
NCT03906838 2019-07-18

Regional Anesthesia Block in Fibula Free Flap Reconstruction

University of Florida

Phase EARLY_PHASE1 Withdrawn
Head & Neck

Head and Neck Neoplasms, Pain, Postoperative

NCT02438852 2019-04-16

Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer

University of Southern California

Phase 3 Withdrawn
Genitourinary

Urinary Bladder Neoplasms, Pain, Postoperative

NCT01943240 2016-10-27

Pectoral Nerve Blockade in Mastectomy

University of New Mexico

Phase 4 Withdrawn
Breast

Breast Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡